North China Co., Ltd. announced that it recently received a “Notice of Shareholding Reduction” issued by Tevo Shanghai, a shareholder holding 5% or more of the shares. From December 25 to 26, 2025, Tevor Shanghai reduced its holdings by 663,600 shares through centralized bidding, accounting for 0.39% of the total share capital. After the equity change, its shareholding fell from 19.15 million shares to 18.486,400 shares, and the ratio fell from 11.26% to 10.87%, hitting the 1% integer scale. This reduction in holdings is in line with the previous plan, does not touch on the proposed acquisition, and will not affect corporate governance and actual control. Tevo Shanghai is still in the holdings reduction plan period, and the company will urge it to reduce its holdings in compliance and disclose information in a timely manner.

North China Co., Ltd. announced that it recently received a “Notice of Shareholding Reduction” issued by Tevo Shanghai, a shareholder holding 5% or more of the shares. From December 25 to 26, 2025, Tevor Shanghai reduced its holdings by 663,600 shares through centralized bidding, accounting for 0.39% of the total share capital. After the equity change, its shareholding fell from 19.15 million shares to 18.486,400 shares, and the ratio fell from 11.26% to 10.87%, hitting the 1% integer scale. This reduction in holdings is in line with the previous plan, does not touch on the proposed acquisition, and will not affect corporate governance and actual control. Tevo Shanghai is still in the holdings reduction plan period, and the company will urge it to reduce its holdings in compliance and disclose information in a timely manner.